Emmaus Life Sciences, Inc. (EMMA)

USD 0.02

(-12.28%)

Long Term Debt Summary of Emmaus Life Sciences, Inc.

  • Emmaus Life Sciences, Inc.'s latest annual long term debt in 2023 was 2.22 Million USD , up 485.79% from previous year.
  • Emmaus Life Sciences, Inc.'s latest quarterly long term debt in 2024 Q2 was 3.55 Million USD , up 0.22% from previous quarter.
  • Emmaus Life Sciences, Inc. reported annual long term debt of 380 Thousand USD in 2022, down -95.2% from previous year.
  • Emmaus Life Sciences, Inc. reported annual long term debt of 7.91 Million USD in 2021, up 15.62% from previous year.
  • Emmaus Life Sciences, Inc. reported quarterly long term debt of 3.79 Million USD for 2024 Q1, up 0.22% from previous quarter.
  • Emmaus Life Sciences, Inc. reported quarterly long term debt of 5.62 Million USD for 2023 Q3, down -0.27% from previous quarter.

Annual Long Term Debt Chart of Emmaus Life Sciences, Inc. (2023 - 1999)

Historical Annual Long Term Debt of Emmaus Life Sciences, Inc. (2023 - 1999)

Year Long Term Debt Long Term Debt Growth
2023 2.22 Million USD 485.79%
2022 380 Thousand USD -95.2%
2021 7.91 Million USD 15.62%
2020 6.84 Million USD 74.01%
2019 3.93 Million USD 566.67%
2018 589.8 Thousand USD 17247.06%
2017 3400.00 USD -90.58%
2016 36.1 Thousand USD -98.69%
2015 2.76 Million USD 87.09%
2014 1.47 Million USD 24538.33%
2013 6000.00 USD 20.0%
2012 5000.00 USD -50.98%
2011 10.2 Thousand USD 200.0%
2010 3400.00 USD -88.82%
2009 30.4 Thousand USD -75.93%
2008 126.3 Thousand USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%

Peer Long Term Debt Comparison of Emmaus Life Sciences, Inc.

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -27725.0%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -26.803%
Qrons Inc. 80 Thousand USD -2682.5%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 89.041%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. 171.23 Thousand USD -1200.006%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 89.354%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -3695.914%
Mesoblast Limited 100.29 Million USD 97.781%
Marizyme, Inc. 667.12 Thousand USD -233.669%
Genus plc 228.2 Million USD 99.025%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 98.66%
Therapeutic Solutions International, Inc. 5512.00 USD -40284.615%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD -0.724%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -58.667%
IMV Inc. 27.39 Million USD 91.875%
AXIM Biotechnologies, Inc. 5.42 Million USD 58.979%
MultiCell Technologies, Inc. 36.43 USD -6110248.614%
ONE Bio Corp. 592.19 Thousand USD -275.888%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 95.997%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -81.217%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -301.378%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -8698.767%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD -17.252%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -591.304%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.98%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -1384.0%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -1255.623%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 85.502%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -49855.117%
Genscript Biotech Corporation 287.12 Million USD 99.225%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -1662.442%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -870.819%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -869.128%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 73.064%
BioStem Technologies, Inc. 265.63 Thousand USD -737.992%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -209110.526%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1387.829%
Regen BioPharma, Inc. 149.61 Thousand USD -1387.829%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -1478.723%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 71.534%
SYBLEU INC 300 Thousand USD -642.0%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -503.172%
International Stem Cell Corporation 445 Thousand USD -400.225%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 72.687%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -387.09%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -91.731%
PureTech Health plc 18.25 Million USD 87.803%
Coeptis Therapeutics, Inc. 150 Thousand USD -1384.0%
IXICO plc 275 Thousand USD -709.455%
IntelGenx Technologies Corp. 11.83 Million USD 81.198%
Gelesis Holdings, Inc. 26.3 Million USD 91.539%
CSL Limited 11.23 Billion USD 99.98%
Cellectis S.A. 36.21 Million USD 93.853%